Recent Blog Posts
World Neglected Tropical Diseases Day: A Call to Action
Each year, January 30 marks World Neglected Tropical Diseases Day, a World Health Organisation (WHO) initiative that sheds light on the need to address these devastating yet preventable illnesses. Affecting an estimated 1 billion people, primarily in underserved...
Collaboration Fuels Success: Pharmalys Team Training 2024
In November 2024, the Pharmalys team came together for a three day training session in Dakar, Senegal, to prepare for an important study on neonatal sepsis. Reflecting the multinational scope of our team, colleagues travelled from across Africa and Europe,...
Exploring the Value of Implementation Research: Highlights from the CREDO Webinar
On 28 November, Pharmalys hosted an online webinar titled ‘Implementation Research: What is it about and what is its value?’ as part of the CREDO (Clinical Research Excellence and Development Opportunity) initiative. CREDO, for which Pharmalys serves as the...
Building Inclusive Digital Health Systems: WHO’s New Strategic Partnership
The digital transformation of healthcare is reshaping how systems operate, creating both opportunities and challenges for equitable health outcomes. In response, the World Health Organisation (WHO) has launched the Strategic Partnership for Data and Digital Health, a...
Acknowledging the 2024 Declaration of Helsinki to Advance Inclusion and Participant Protection in Clinical Research
The recent revision of the Declaration of Helsinki, adopted at the 2024 General Assembly of the World Medical Association (WMA) in Helsinki, represents a pivotal moment in the evolution of ethical standards for medical research involving human participants. This...
CREDO Free Webinar: Implementation research: what is it about and what is its value?
Implementation research: what is it about and what is its value? A free webinar by Pharmalys Ltd, CREDO Institutional Sponsor 28 November 2024 13:00-15:00 Greenwich Mean Time Panellists: Piero Olliaro, Prof. of poverty related infectious diseases,...
Breast Cancer Awareness Month: Pharmalys’ Commitment to Women’s Health
October marks Breast Cancer Awareness Month, a time to reflect on the impact breast cancer has on millions of women worldwide and to reaffirm our commitment to supporting the cause. As a clinical research organisation involved in maternal and child health, Pharmalys...
Long COVID in Children and Teenagers
The PostAcute Sequelae of SARSCoV-2 (PASC) The COVID-19 pandemic has caused widespread devastation, with the immediate and short-term effects of SARS-CoV-2 infection now well described. While most people recover, many experience longer-lasting effects known as long...
Development of Global Precision Medicine: Pharmalys Ltd at the EU-Africa PerMed Workshop 2024
EU-Africa PerMed (Building Links Between Europe and Africa in Personalised* Medicine) is an international project funded by the European Commission’s Horizon 2020 programme. Its goal is to integrate more African countries into the global Precision Medicine (PM)...
New WHO Guidance on Best Practices for Clinical Trials
The clinical trial landscape has undergone significant changes since the concept of trials was first introduced, with notable shifts in the social, ethical, and regulatory environments worldwide. The Clinical Trial Landscape Is Evolving Today, there is a broader...